Annual EPS
-$5.58
+$13.88+71.31%
31 December 2023
Summary:
GT Biopharma annual earnings per share is currently -$5.58, with the most recent change of +$13.88 (+71.31%) on 31 December 2023. During the last 3 years, it has risen by +$187.92 (+97.11%). GTBP annual EPS is now -100.00% below its all-time high of $32.52 million, reached on 31 December 1990.GTBP EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$1.53
+$0.64+29.49%
30 September 2024
Summary:
GT Biopharma quarterly earnings per share is currently -$1.53, with the most recent change of +$0.64 (+29.49%) on 30 September 2024. Over the past year, it has increased by +$0.24 (+13.56%). GTBP quarterly EPS is now -100.00% below its all-time high of $13.39 million, reached on 30 June 1989.GTBP Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$7.45
+$0.24+3.12%
30 September 2024
Summary:
GT Biopharma TTM earnings per share is currently -$7.45, with the most recent change of +$0.24 (+3.12%) on 30 September 2024. Over the past year, it has increased by +$1.08 (+12.65%). GTBP TTM EPS is now -100.00% below its all-time high of $28.69 million, reached on 30 September 1990.GTBP TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +71.3% | +13.6% | +12.7% |
| 3 y3 years | +97.1% | +70.0% | +92.8% |
| 5 y5 years | +99.8% | +99.4% | +98.0% |
GTBP EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +97.1% | -628.6% | +90.2% | -33.5% | +92.8% |
| 5 y | 5 years | at high | +99.8% | -116.3% | +99.4% | -33.5% | +98.1% |
| alltime | all time | -100.0% | +100.0% | -100.0% | +100.0% | -100.0% | +100.0% |
GT Biopharma EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.53(-29.5%) | -$7.45(-3.1%) |
| June 2024 | - | -$2.17(+32.3%) | -$7.69(+9.7%) |
| Mar 2024 | - | -$1.64(-22.4%) | -$7.01(+25.6%) |
| Dec 2023 | -$5.58(-71.3%) | -$2.11(+19.4%) | -$5.58(-34.6%) |
| Sept 2023 | - | -$1.77(+18.8%) | -$8.53(-36.1%) |
| June 2023 | - | -$1.49(+609.5%) | -$13.36(-10.2%) |
| Mar 2023 | - | -$0.21(-95.9%) | -$14.87(-24.7%) |
| Dec 2022 | -$19.46(-68.5%) | -$5.06(-23.3%) | -$19.76(-34.8%) |
| Sept 2022 | - | -$6.60(+120.0%) | -$30.30(+5.2%) |
| June 2022 | - | -$3.00(-41.2%) | -$28.80(-5.0%) |
| Mar 2022 | - | -$5.10(-67.3%) | -$30.30(-62.2%) |
| Dec 2021 | -$61.80(-68.1%) | -$15.60(+205.9%) | -$80.10(-23.1%) |
| Sept 2021 | - | -$5.10(+13.3%) | -$104.10(-11.9%) |
| June 2021 | - | -$4.50(-91.8%) | -$118.20(-50.2%) |
| Mar 2021 | - | -$54.90(+38.6%) | -$237.30(+21.9%) |
| Dec 2020 | -$193.50(-43.5%) | -$39.60(+106.3%) | -$194.70(+33.6%) |
| Sept 2020 | - | -$19.20(-84.5%) | -$145.68(-62.3%) |
| June 2020 | - | -$123.60(+904.9%) | -$386.58(+34.0%) |
| Mar 2020 | - | -$12.30(-230.6%) | -$288.48(-10.4%) |
| Dec 2019 | -$342.48(-87.0%) | $9.42(-103.6%) | -$322.08(-12.3%) |
| Sept 2019 | - | -$260.10(+920.0%) | -$367.20(-85.3%) |
| June 2019 | - | -$25.50(-44.4%) | -$2504.08(-2.6%) |
| Mar 2019 | - | -$45.90(+28.6%) | -$2570.38(-2.1%) |
| Dec 2018 | -$2631.58(-40.0%) | -$35.70(-98.5%) | -$2626.48(-1.0%) |
| Sept 2018 | - | -$2396.98(+2511.1%) | -$2652.10(-39.9%) |
| June 2018 | - | -$91.80(-10.0%) | -$4411.59(-35.6%) |
| Mar 2018 | - | -$102.00(+66.3%) | -$6851.13(-47.5%) |
| Dec 2017 | -$4385.96(-109.2%) | -$61.32(-98.5%) | -$13.05 K(-51.4%) |
| Sept 2017 | - | -$4156.47(+64.2%) | -$26.85 K(-36.7%) |
| June 2017 | - | -$2531.35(-59.8%) | -$42.43 K(+37.9%) |
| Mar 2017 | - | -$6298.88(-54.6%) | -$30.76 K(-138.6%) |
| Dec 2016 | $47.88 K(-103.4%) | -$13.87 K(-29.7%) | $79.68 K(-104.8%) |
| Sept 2016 | - | -$19.73 K(-316.1%) | -$1.65 M(-5.4%) |
| June 2016 | - | $9130.18(-91.2%) | -$1.74 M(-4129.5%) |
| Mar 2016 | - | $104.14 K(-106.0%) | $43.14 K(-103.0%) |
| Dec 2015 | -$1.43 M(-8.8%) | -$1.74 M(+1441.5%) | -$1.43 M(+53.3%) |
| Sept 2015 | - | -$112.80 K(-106.3%) | -$932.27 K(-15.3%) |
| June 2015 | - | $1.79 M(-230.9%) | -$1.10 M(-62.2%) |
| Mar 2015 | - | -$1.37 M(+10.1%) | -$2.91 M(+85.5%) |
| Dec 2014 | -$1.57 M(+4275.9%) | -$1.24 M(+341.6%) | -$1.57 M(+345.9%) |
| Sept 2014 | - | -$281.33 K(+1403.3%) | -$351.83 K(+277.2%) |
| June 2014 | - | -$18.71 K(-29.4%) | -$93.29 K(-3.3%) |
| Mar 2014 | - | -$26.50 K(+4.8%) | -$96.43 K(+164.2%) |
| Dec 2013 | -$35.79 K(-91.0%) | -$25.29 K(+11.0%) | -$36.50 K(-47.7%) |
| Sept 2013 | - | -$22.79 K(+4.2%) | -$69.75 K(-60.0%) |
| June 2013 | - | -$21.86 K(-165.4%) | -$174.24 K(-58.4%) |
| Mar 2013 | - | $33.43 K(-157.1%) | -$418.49 K(-22.5%) |
| Dec 2012 | -$397.77 K(-24.7%) | -$58.54 K(-54.0%) | -$539.78 K(-16.2%) |
| Sept 2012 | - | -$127.27 K(-52.2%) | -$643.81 K(+25.6%) |
| June 2012 | - | -$266.11 K(+202.9%) | -$512.71 K(+35.3%) |
| Mar 2012 | - | -$87.86 K(-46.0%) | -$379.00 K(-50.9%) |
| Dec 2011 | -$528.57 K(-47.5%) | -$162.57 K(-4341.0%) | -$771.89 K(-7.9%) |
| Sept 2011 | - | $3833.33(-102.9%) | -$837.65 K(-20.4%) |
| June 2011 | - | -$132.40 K(-72.5%) | -$1.05 M(+33.7%) |
| Mar 2011 | - | -$480.75 K(+110.5%) | -$787.08 K(-41.9%) |
| Dec 2010 | -$1.01 M(-55.2%) | -$228.33 K(+8.2%) | -$1.36 M(-45.0%) |
| Sept 2010 | - | -$211.00 K(-258.6%) | -$2.46 M(-2.3%) |
| June 2010 | - | $133.00 K(-112.7%) | -$2.52 M(-16.2%) |
| Mar 2010 | - | -$1.05 M(-21.5%) | -$3.01 M(+34.0%) |
| Dec 2009 | -$2.25 M(-55.1%) | -$1.34 M(+398.9%) | -$2.25 M(+50.6%) |
| Sept 2009 | - | -$268.00 K(-24.5%) | -$1.49 M(-26.2%) |
| June 2009 | - | -$355.00 K(+24.1%) | -$2.02 M(-51.9%) |
| Mar 2009 | - | -$286.00 K(-50.9%) | -$4.20 M(-16.1%) |
| Dec 2008 | -$5.01 M(-1162.8%) | -$582.00 K(-27.0%) | -$5.01 M(+20.8%) |
| Sept 2008 | - | -$797.00 K(-68.5%) | -$4.14 M(+19.5%) |
| June 2008 | - | -$2.53 M(+131.5%) | -$3.47 M(-2396.0%) |
| Mar 2008 | - | -$1.09 M(-490.7%) | $151.00 K(-67.9%) |
| Dec 2007 | $471.00 K | $280.00 K(-333.3%) | $471.00 K(-116.7%) |
| Sept 2007 | - | -$120.00 K(-111.1%) | -$2.83 M(-15.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2007 | - | $1.08 M(-240.2%) | -$3.36 M(-33.1%) |
| Mar 2007 | - | -$774.00 K(-74.4%) | -$5.02 M(+1.7%) |
| Dec 2006 | -$4.94 M(+58.9%) | -$3.02 M(+362.2%) | -$4.94 M(+18.6%) |
| Sept 2006 | - | -$653.00 K(+12.8%) | -$4.16 M(+8.7%) |
| June 2006 | - | -$579.00 K(-16.1%) | -$3.83 M(+7.9%) |
| Mar 2006 | - | -$690.00 K(-69.2%) | -$3.55 M(+14.2%) |
| Dec 2005 | -$3.11 M(+15.2%) | -$2.24 M(+605.0%) | -$3.11 M(+80.1%) |
| Sept 2005 | - | -$318.00 K(+6.0%) | -$1.73 M(+22.6%) |
| June 2005 | - | -$300.00 K(+20.5%) | -$1.41 M(+27.1%) |
| Mar 2005 | - | -$249.00 K(-71.0%) | -$1.11 M(+29.0%) |
| Dec 2004 | -$2.70 M(-48.1%) | -$859.00 K(-82.7%) | -$859.00 K(-95.6%) |
| Sept 1999 | - | -$4.97 M(-43.5%) | -$19.51 M(-21.5%) |
| June 1999 | - | -$8.80 M(+53.3%) | -$24.86 M(+14.0%) |
| Mar 1999 | - | -$5.74 M(-44.4%) | -$21.80 M(-25.9%) |
| Sept 1998 | - | -$10.33 M(+80.0%) | -$29.41 M(0.0%) |
| June 1998 | - | -$5.74 M(-53.1%) | -$29.41 M(-20.6%) |
| Mar 1998 | - | -$12.24 M(+1012.8%) | -$37.06 M(-15.7%) |
| Dec 1997 | -$5.20 M(-94.2%) | -$1.10 M(-89.3%) | -$43.94 M(-0.9%) |
| Sept 1997 | - | -$10.33 M(-22.9%) | -$44.34 M(-19.5%) |
| June 1997 | - | -$13.39 M(-30.0%) | -$55.05 M(-14.8%) |
| Mar 1997 | - | -$19.13 M(+1175.1%) | -$64.62 M(-8.2%) |
| Dec 1996 | -$89.90 M(+910.1%) | -$1.50 M(-92.9%) | -$70.36 M(-0.4%) |
| Sept 1996 | - | -$21.04 M(-8.3%) | -$70.66 M(-44.8%) |
| June 1996 | - | -$22.95 M(-7.7%) | -$128.04 M(-4.3%) |
| Mar 1996 | - | -$24.86 M(+1281.4%) | -$133.77 M(+7.7%) |
| Dec 1995 | -$8.90 M(-94.7%) | -$1.80 M(-97.7%) | -$124.21 M(+0.8%) |
| Sept 1995 | - | -$78.42 M(+173.3%) | -$123.21 M(-32.5%) |
| June 1995 | - | -$28.69 M(+87.5%) | -$182.50 M(+13.0%) |
| Mar 1995 | - | -$15.30 M(+1812.7%) | -$161.46 M(+5.0%) |
| Dec 1994 | -$168.32 M(+193.3%) | -$800.00 K(-99.4%) | -$153.81 M(+0.5%) |
| Sept 1994 | - | -$137.71 M(+1700.0%) | -$153.11 M(+398.7%) |
| June 1994 | - | -$7.65 M(0.0%) | -$30.70 M(-48.3%) |
| Mar 1994 | - | -$7.65 M(+7550.7%) | -$59.39 M(+10.7%) |
| Dec 1993 | -$57.38 M(+328.6%) | -$100.00 K(-99.3%) | -$53.65 M(-0.2%) |
| Sept 1993 | - | -$15.30 M(-57.9%) | -$53.75 M(+33.2%) |
| June 1993 | - | -$36.34 M(+1800.0%) | -$40.37 M(+878.5%) |
| Mar 1993 | - | -$1.91 M(+856.3%) | -$4.13 M(-31.7%) |
| Dec 1992 | -$13.39 M(+75.0%) | -$200.00 K(-89.5%) | -$6.04 M(+1.7%) |
| Sept 1992 | - | -$1.91 M(+1812.7%) | -$5.94 M(0.0%) |
| June 1992 | - | -$100.00 K(-97.4%) | -$5.94 M(-23.4%) |
| Mar 1992 | - | -$3.83 M(+3725.4%) | -$7.75 M(+97.5%) |
| Dec 1991 | -$7.65 M(-123.5%) | -$100.00 K(-94.8%) | -$3.93 M(+2.6%) |
| Sept 1991 | - | -$1.91 M(0.0%) | -$3.83 M(<-9900.0%) |
| June 1991 | - | -$1.91 M(-200.0%) | $0.00(-100.0%) |
| Dec 1990 | $32.52 M(+13.3%) | - | - |
| Sept 1990 | - | $1.91 M(-85.7%) | $28.69 M(+7.1%) |
| June 1990 | - | $13.39 M(0.0%) | $26.78 M(0.0%) |
| Mar 1990 | - | $13.39 M(0.0%) | $26.78 M(+16.7%) |
| Dec 1989 | $28.69 M(+400.0%) | - | - |
| June 1989 | - | $13.39 M(+75.0%) | $22.95 M(+71.4%) |
| Mar 1989 | - | $7.65 M(+300.0%) | $13.39 M(+133.3%) |
| Dec 1988 | $5.74 M(-50.0%) | - | - |
| Sept 1988 | - | $1.91 M(-50.0%) | $5.74 M(+200.0%) |
| June 1988 | - | $3.83 M(-300.0%) | $1.91 M(-50.0%) |
| Dec 1987 | $11.48 M(-175.0%) | - | - |
| Sept 1987 | - | -$1.91 M(-133.3%) | $3.83 M(-166.7%) |
| Mar 1987 | - | $5.74 M(-250.0%) | -$5.74 M(0.0%) |
| Dec 1986 | -$15.30 M(+14.3%) | - | - |
| Sept 1986 | - | -$3.83 M(-50.0%) | -$5.74 M(0.0%) |
| June 1986 | - | -$7.65 M(-233.3%) | -$5.74 M(<-9900.0%) |
| Mar 1986 | - | $5.74 M(-250.0%) | $0.00(-100.0%) |
| Dec 1985 | -$13.39 M(-275.0%) | - | - |
| Sept 1985 | - | -$3.83 M(+100.0%) | -$9.56 M(+150.0%) |
| June 1985 | - | -$1.91 M(-50.0%) | -$3.83 M(>+9900.0%) |
| Mar 1985 | - | -$3.83 M(-300.0%) | -$0.00(-100.0%) |
| Dec 1984 | $7.65 M(-33.3%) | - | - |
| Sept 1984 | - | $1.91 M(0.0%) | $5.74 M(+50.0%) |
| June 1984 | - | $1.91 M(0.0%) | $3.83 M(+100.0%) |
| Mar 1984 | - | $1.91 M | $1.91 M |
| Feb 1984 | $11.48 M | - | - |
FAQ
- What is GT Biopharma annual earnings per share?
- What is the all time high annual EPS for GT Biopharma?
- What is GT Biopharma annual EPS year-on-year change?
- What is GT Biopharma quarterly earnings per share?
- What is the all time high quarterly EPS for GT Biopharma?
- What is GT Biopharma quarterly EPS year-on-year change?
- What is GT Biopharma TTM earnings per share?
- What is the all time high TTM EPS for GT Biopharma?
- What is GT Biopharma TTM EPS year-on-year change?
What is GT Biopharma annual earnings per share?
The current annual EPS of GTBP is -$5.58
What is the all time high annual EPS for GT Biopharma?
GT Biopharma all-time high annual earnings per share is $32.52 M
What is GT Biopharma annual EPS year-on-year change?
Over the past year, GTBP annual earnings per share has changed by +$13.88 (+71.31%)
What is GT Biopharma quarterly earnings per share?
The current quarterly EPS of GTBP is -$1.53
What is the all time high quarterly EPS for GT Biopharma?
GT Biopharma all-time high quarterly earnings per share is $13.39 M
What is GT Biopharma quarterly EPS year-on-year change?
Over the past year, GTBP quarterly earnings per share has changed by +$0.24 (+13.56%)
What is GT Biopharma TTM earnings per share?
The current TTM EPS of GTBP is -$7.45
What is the all time high TTM EPS for GT Biopharma?
GT Biopharma all-time high TTM earnings per share is $28.69 M
What is GT Biopharma TTM EPS year-on-year change?
Over the past year, GTBP TTM earnings per share has changed by +$1.08 (+12.65%)